Literature DB >> 16943440

Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.

Gary P H Ho1, Steven Margossian, Toshiyasu Taniguchi, Alan D D'Andrea.   

Abstract

The Fanconi anemia (FA) pathway is a DNA damage-activated signaling pathway which regulates cellular resistance to DNA cross-linking agents. Cloned FA genes and proteins cooperate in this pathway, and monoubiquitination of FANCD2 is a critical downstream event. The cell cycle checkpoint kinase ATR is required for the efficient monoubiquitination of FANCD2, while another checkpoint kinase, ATM, directly phosphorylates FANCD2 and controls the ionizing radiation (IR)-inducible intra-S-phase checkpoint. In the present study, we identify two novel DNA damage-inducible phosphorylation sites on FANCD2, threonine 691 and serine 717. ATR phosphorylates FANCD2 on these two sites, thereby promoting FANCD2 monoubiquitination and enhancing cellular resistance to DNA cross-linking agents. Phosphorylation of the sites is required for establishment of the intra-S-phase checkpoint response. IR-inducible phosphorylation of threonine 691 and serine 717 is also dependent on ATM and is more strongly impaired when both ATM and ATR are knocked down. Threonine 691 is phosphorylated during normal S-phase progression in an ATM-dependent manner. These findings further support the functional connection of ATM/ATR kinases and FANCD2 in the DNA damage response and support a role for the FA pathway in the coordination of the S phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943440      PMCID: PMC1592857          DOI: 10.1128/MCB.02018-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems.

Authors:  Susan M Gordon; Manuel Buchwald
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

2.  ATR and ATM regulate the timing of DNA replication origin firing.

Authors:  David Shechter; Vincenzo Costanzo; Jean Gautier
Journal:  Nat Cell Biol       Date:  2004-06-27       Impact factor: 28.824

3.  Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.

Authors:  C E Canman; D S Lim; K A Cimprich; Y Taya; K Tamai; K Sakaguchi; E Appella; M B Kastan; J D Siliciano
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

4.  Fragments of ATM which have dominant-negative or complementing activity.

Authors:  S E Morgan; C Lovly; T K Pandita; Y Shiloh; M B Kastan
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

5.  Enhanced phosphorylation of p53 by ATM in response to DNA damage.

Authors:  S Banin; L Moyal; S Shieh; Y Taya; C W Anderson; L Chessa; N I Smorodinsky; C Prives; Y Reiss; Y Shiloh; Y Ziv
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

6.  Recombinant ATM protein complements the cellular A-T phenotype.

Authors:  Y Ziv; A Bar-Shira; I Pecker; P Russell; T J Jorgensen; I Tsarfati; Y Shiloh
Journal:  Oncogene       Date:  1997-07-10       Impact factor: 9.867

7.  A novel ubiquitin ligase is deficient in Fanconi anemia.

Authors:  Amom Ruhikanta Meetei; Johan P de Winter; Annette L Medhurst; Michael Wallisch; Quinten Waisfisz; Henri J van de Vrugt; Anneke B Oostra; Zhijiang Yan; Chen Ling; Colin E Bishop; Maureen E Hoatlin; Hans Joenje; Weidong Wang
Journal:  Nat Genet       Date:  2003-09-14       Impact factor: 38.330

8.  Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after x-irradiation.

Authors:  F Zampetti-Bosseler; D Scott
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1981-05

9.  ATR couples FANCD2 monoubiquitination to the DNA-damage response.

Authors:  Paul R Andreassen; Alan D D'Andrea; Toshiyasu Taniguchi
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

10.  FANCG is phosphorylated at serines 383 and 387 during mitosis.

Authors:  Jun Mi; Fengyu Qiao; James B Wilson; Anthony A High; Melanie J Schroeder; Peter T Stukenberg; Amy Moss; Jeffrey Shabanowitz; Donald F Hunt; Nigel J Jones; Gary M Kupfer
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more
  65 in total

Review 1.  The Fanconi anemia pathway and DNA interstrand cross-link repair.

Authors:  Xiaoyu Su; Jun Huang
Journal:  Protein Cell       Date:  2011-09-23       Impact factor: 14.870

2.  Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair.

Authors:  Luca Colnaghi; Mathew J K Jones; Xiomaris M Cotto-Rios; Detlev Schindler; Helmut Hanenberg; Tony T Huang
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

3.  FANCI binds branched DNA and is monoubiquitinated by UBE2T-FANCL.

Authors:  Simonne Longerich; Joseph San Filippo; Dongqing Liu; Patrick Sung
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

4.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

5.  The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI.

Authors:  Stacy A Williams; Simonne Longerich; Patrick Sung; Cyrus Vaziri; Gary M Kupfer
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

Review 6.  The Fanconi anemia ID2 complex: dueling saxes at the crossroads.

Authors:  Rebecca A Boisvert; Niall G Howlett
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 7.  Mouse models of DNA double-strand break repair and neurological disease.

Authors:  Pierre-Olivier Frappart; Peter J McKinnon
Journal:  DNA Repair (Amst)       Date:  2008-05-23

8.  Regulation of PCNA polyubiquitination in human cells.

Authors:  Jan Brun; Roland K Chiu; Bradly G Wouters; Douglas A Gray
Journal:  BMC Res Notes       Date:  2010-03-30

Review 9.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

10.  Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.

Authors:  Igor Landais; Sanne Hiddingh; Matthew McCarroll; Chao Yang; Aiming Sun; Mitchell S Turker; James P Snyder; Maureen E Hoatlin
Journal:  Mol Cancer       Date:  2009-12-31       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.